Spain – Pharmaceutical products – Suministro de Eptacog alfa activado (DOE)
awardedOSAKIDETZA - Servicio Vasco de Salud - Organización Central · S5100023J
Description
Suministro de Eptacog alfa activado (DOE)
Key facts
- Procedure
- neg-wo-call
- Contact
- contrata@osakidetza.eus
- Pre-award estimate
- €5.2m
- Regime
- publicSector
- Contract references
- 2026/01479252_00001
- Category
- supplies
Awarded suppliers
- NOVO NORDISK PHARMA, S.A. · A28081495 · ES300, ES
Supplier location as published: Madrid, ES300, 28033, ES
Ground given for limiting competition
The buyer’s own stated reason for awarding without open competition, as published. Their assertion, not a finding.
technical
El presente procedimiento requiere de negociación para adjudicar la necesidad del contrato al licitador justificadamente elegido por el órgano de contratación. Ver Pliego de Cláusulas Administrativas
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- ted-eu
- Notice id
- 778275-2026
- First seen
- 9 Nov 2026
- Last updated
- 9 Nov 2026
Licence EU reuse — Commission Decision 2011/833/EU ↗
Source: TED — Tenders Electronic Daily (ted.europa.eu), © European Union, reused under Commission Decision 2011/833/EU.
GET /api/v1/tenders/3c5b4370-4d62-4cfd-b423-a59770ab724aThe source notice is authoritative — verify deadlines and documents there before bidding.